Health tech companies weigh funding options amid weak IPO market

Health tech companies weigh funding options amid weak IPO market

Source: 
BioPharma Dive
snippet: 

The IPO market for healthcare tech companies is facing its worst year in two decades as the COVID-19 pandemic, Russia’s war in Ukraine, record-high inflation and rising interest rates have squeezed public market valuations and sent stocks plunging.